These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9497913)
1. Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival. McMenamin ME; O'Neill AJ; Gaffney EF Mol Pathol; 1997 Oct; 50(5):242-6. PubMed ID: 9497913 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic bodies as a morphological feature in serous ovarian carcinoma: correlation with nuclear grade, Ki-67 and mitotic indices. Brustmann H Pathol Res Pract; 2002; 198(2):85-90. PubMed ID: 11928869 [TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical comparison of P53 and Bcl-2 as apoptotic and MIB1 as proliferative markers in low-grade and high-grade ovarian serous carcinomas. Mishra SK; Crasta JA Int J Gynecol Cancer; 2010 May; 20(4):537-41. PubMed ID: 20442586 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage. Brustmann H; Naudé S Gynecol Oncol; 2002 Jan; 84(1):47-52. PubMed ID: 11748975 [TBL] [Abstract][Full Text] [Related]
5. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma. Shin K; Kim KH; Yoon MS; Suh DS; Lee JY; Kim A; Eo W Adv Clin Exp Med; 2016; 25(3):513-21. PubMed ID: 27629740 [TBL] [Abstract][Full Text] [Related]
6. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. Brustmann H Gynecol Oncol; 2004 Jan; 92(1):268-76. PubMed ID: 14751170 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas]. Shen XX; Yu L; Bi R; Yang WT Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637 [TBL] [Abstract][Full Text] [Related]
8. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
10. [Evaluation of two-tier grading system and significance of p53 protein over-expression in ovarian serous carcinoma]. Lin J; Du J; Zhang CY; Xie QT; Zhang B; Liu CR Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):655-60. PubMed ID: 21176529 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax). de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311 [TBL] [Abstract][Full Text] [Related]
14. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors. Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between P53 Protein Expression and Prognosis of Advanced Ovarian Serous Adenocarcinoma]. Zuo J; Song Y; Li Z; Wu LY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):169-74. PubMed ID: 27181893 [TBL] [Abstract][Full Text] [Related]
16. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
17. The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas. Köbel M; Reuss A; du Bois A; Kommoss S; Kommoss F; Gao D; Kalloger SE; Huntsman DG; Gilks CB J Pathol; 2010 Oct; 222(2):191-8. PubMed ID: 20629008 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Soini Y; Virkajärvi N; Lehto VP; Pääkkö P Br J Cancer; 1996 May; 73(9):1025-30. PubMed ID: 8624258 [TBL] [Abstract][Full Text] [Related]
19. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma. Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286 [TBL] [Abstract][Full Text] [Related]
20. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors. Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]